TY - JOUR
T1 - The Risks of Risk Assessment
T2 - Causal Blind Spots When Using Prediction Models for Treatment Decisions
AU - van Geloven, Nan
AU - Keogh, Ruth H
AU - van Amsterdam, Wouter
AU - Cinà, Giovanni
AU - Krijthe, Jesse H
AU - Peek, Niels
AU - Luijken, Kim
AU - Magliacane, Sara
AU - Morzywołek, Paweł
AU - van Ommen, Thijs
AU - Putter, Hein
AU - Sperrin, Matthew
AU - Wang, Junfeng
AU - Weir, Daniala L
AU - Didelez, Vanessa
N1 - Publisher Copyright:
© 2025 American College of Physicians.
PY - 2025/9
Y1 - 2025/9
N2 - Clinicians increasingly rely on prediction models to guide treatment choices. Most prediction models, however, are developed using observational data that include some patients who have already received the treatment the prediction model is meant to inform. Special attention to the causal role of those earlier treatments is required when interpreting the resulting predictions. "Causal blind spots" were identified in 3 common approaches to handling treatment when developing a prediction model: including treatment as a predictor, restricting to persons taking a certain treatment, and ignoring treatment. Through several real examples, this article illustrates how the risks obtained from models developed using such approaches may be misinterpreted and can lead to misinformed decision making. The discussion covers issues attributable to confounding, selection, mediation, and changes in treatment protocols over time. An extension of guidelines for the development, reporting, and evaluation of prediction models is advocated to avoid such misinterpretations. Developers must ensure that the intended target population for the model, and the treatment conditions under which predictions hold, are clearly communicated. When prediction models are intended to inform treatment decisions, they need to provide estimates of risk under the specific treatment (or intervention) options being considered, known as "prediction under interventions." Next to suitable data, this requires causal reasoning and causal inference techniques during model development and evaluation. Being clear about what a given prediction model can and cannot be used for prevents misinformed treatment decisions and thereby prevents potential harm to patients.
AB - Clinicians increasingly rely on prediction models to guide treatment choices. Most prediction models, however, are developed using observational data that include some patients who have already received the treatment the prediction model is meant to inform. Special attention to the causal role of those earlier treatments is required when interpreting the resulting predictions. "Causal blind spots" were identified in 3 common approaches to handling treatment when developing a prediction model: including treatment as a predictor, restricting to persons taking a certain treatment, and ignoring treatment. Through several real examples, this article illustrates how the risks obtained from models developed using such approaches may be misinterpreted and can lead to misinformed decision making. The discussion covers issues attributable to confounding, selection, mediation, and changes in treatment protocols over time. An extension of guidelines for the development, reporting, and evaluation of prediction models is advocated to avoid such misinterpretations. Developers must ensure that the intended target population for the model, and the treatment conditions under which predictions hold, are clearly communicated. When prediction models are intended to inform treatment decisions, they need to provide estimates of risk under the specific treatment (or intervention) options being considered, known as "prediction under interventions." Next to suitable data, this requires causal reasoning and causal inference techniques during model development and evaluation. Being clear about what a given prediction model can and cannot be used for prevents misinformed treatment decisions and thereby prevents potential harm to patients.
UR - https://www.scopus.com/pages/publications/105016388470
U2 - 10.7326/ANNALS-24-00279
DO - 10.7326/ANNALS-24-00279
M3 - Article
C2 - 40720833
SN - 0003-4819
VL - 178
SP - 1326
EP - 1333
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 9
ER -